Reuters logo
BRIEF-Valbiotis launches "pivotal" REVERSE-IT clinical trial of VALEDIA
November 8, 2017 / 4:59 PM / 11 days ago

BRIEF-Valbiotis launches "pivotal" REVERSE-IT clinical trial of VALEDIA

Nov 8 (Reuters) - VALBIOTIS SAS:

* VALBIOTIS: VALEDIA: LAUNCH OF “PIVOTAL” REVERSE-IT CLINICAL TRIAL TO OBTAIN A HEALTH CLAIM

* ‍FIRST SUBJECTS WILL BE INCLUDED IN TRIAL EARLY 2018​

* ‍INCREASED FINANCIAL SUPPORT FROM PUBLIC PARTNER INSTITUTIONS, UP TO MEUR 1,05 SINCE SEPTEMBER 2017​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below